How Dr. Ravi Chauhan and the Conrad Pearson Clinic Are Leading the Way with Adstiladrin Gene Therapy
A Breakthrough in Bladder Cancer Care
At Conrad Pearson Clinic, our mission is to provide cutting-edge, compassionate care for patients throughout the Memphis region. One of the most exciting new developments in urology is Adstiladrin— an FDA-approved gene therapy for non–muscle invasive bladder cancer (NMIBC).
Dr. Ravi D. Chauhan, MD, FACS, a leading urologist in Memphis, who leads the bladder and kidney cancer clinic at Conrad Pearson, has been at the forefront of integrating this advanced treatment into patient care.“ We’re seeing tremendous enthusiasm from patients,” says Dr. Chauhan. “The fact that Adstiladrin is given just once every three months makes it convenient and less burdensome, while still offering excellent results.”
What Makes Adstiladrin Different?
Unlike traditional treatments such as BCG therapy, which require frequent visits and can be hard on patients, Adstiladrin is administered only once every three months. It’s delivered directly into the bladder through a catheter and uses gene therapy to help the body fight cancer from within. This therapy works by turning bladder cells into mini “interferon factories.” These cells then produce a natural cancer-fighting protein called interferon alfa-2b, which continues working even after treatment sessions are over. “It’s a remarkable technology,” Dr. Chauhan explains. “We’re transforming the bladder into its own cancer-fighting environment — safely and effectively.”
Designed for Patient Convenience and Comfort
Patients appreciate the reduced number of clinic visits and the lower rate of side effects compared to traditional chemotherapy or immunotherapy. Instead of weekly treatments, Adstiladrin offers a quarterly schedule — just four treatments a year.
At Conrad Pearson Clinic, our team is dedicated to ensuring that each patient’s treatment plan runs smoothly. We rely on a collaborative care model that includes:
- Nurse Navigators who track treatment schedules and follow-up appointments
- Advanced Practice Providers (APPs) who assist with patient education and monitoring
- Team meetings where Dr. Chauhan and staff review each patient’s progress
It’s truly a team effort and the coordinated approach ensures that patients receive timely care, consistent communication, and peace of mind. Dr. Chauhan helps each patient explore the treatment options best suited to their diagnosis and lifestyle. While systemic immunotherapy drugs like Keytruda can play an important role newer treatments like Adstiladrin are prescribed for their ease of use, lower toxicity, and convenience.
The Future of Bladder Cancer Treatment
Dr. Chauhan is excited about what’s to come. Clinical trials are expanding options for both BCG-refractory and BCG-naive bladder cancers, giving more patients access to effective, personalized care. “We now have more tools than ever to fight bladder cancer,” says Dr. Chauhan. “Adstiladrin represents a major step forward — and it’s only the beginning.” Dr. Chauhan also notes that industry support programs are helping practices and patients navigate the financial aspects of advanced therapies, ensuring that cost is less of a barrier to care.
About Dr. Ravi D. Chauhan
Dr. Ravi Chauhan is a board-certified urologist at Conrad Pearson Clinic in Memphis, Tennessee, who has been nationally recognized for his specialization in bladder cancer and minimally invasive urologic treatments. With a passion for bringing advanced therapies to community practice, Dr. Chauhan is recognized for his patient-centered approach and leadership in adopting innovative cancer treatments like Adstiladrin.
Dr. Chauhan was featured in Urology Times and you can read or listen to the full article here: https://www.urologytimes.com/view/ravi-chauhan-md-discusses-integrating-nadofaragene-into-clinical-practice
Ready to Learn More?
If you or someone you love has been diagnosed with non–muscle invasive bladder cancer, you don’t have to face it alone. Talk to Dr. Ravi Chauhan and the caring team at Conrad Pearson Clinic about whether Adstiladrin might be the right choice for you.
